series-a
Stage
2019
Founded
2
Investors
About
Apmonia Therapeutics is a biotech company developing therapeutic strategies for multiple types of cancer, focusing on next-generation peptide-based therapies targeting the tumor microenvironment to improve patient outcomes.
Explore Apmonia therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.